nby20220630_10q.htm

0001389545 NOVABAY PHARMACEUTICALS, INC. false --12-31 Q2 2022 0 0 522 641 0.01 0.01 5,000 5,000 12 12 14 14 0.01 0.01 150,000 100,000 53,513 53,513 47,766 47,766 0 5 7 3 5 5 7 0 0 4.5 0 2 0 5.5 5 10 10 5 4 0 0 0 0 00013895452022-01-012022-06-30 00013895452022-08-09 thunderdome:item iso4217:USD 00013895452022-06-30 00013895452021-12-31 iso4217:USDxbrli:shares 0001389545us-gaap:ProductMember2022-04-012022-06-30 0001389545us-gaap:ProductMember2021-04-012021-06-30 0001389545us-gaap:ProductMember2022-01-012022-06-30 0001389545us-gaap:ProductMember2021-01-012021-06-30 0001389545us-gaap:ProductAndServiceOtherMember2022-04-012022-06-30 0001389545us-gaap:ProductAndServiceOtherMember2021-04-012021-06-30 0001389545us-gaap:ProductAndServiceOtherMember2022-01-012022-06-30 0001389545us-gaap:ProductAndServiceOtherMember2021-01-012021-06-30 00013895452022-04-012022-06-30 00013895452021-04-012021-06-30 00013895452021-01-012021-06-30 0001389545us-gaap:PreferredStockMember2021-12-31 0001389545us-gaap:CommonStockMember2021-12-31 0001389545us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001389545us-gaap:RetainedEarningsMember2021-12-31 0001389545us-gaap:PreferredStockMember2022-01-012022-03-31 0001389545us-gaap:CommonStockMember2022-01-012022-03-31 0001389545us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-31 0001389545us-gaap:RetainedEarningsMember2022-01-012022-03-31 00013895452022-01-012022-03-31 0001389545us-gaap:PreferredStockMember2022-03-31 0001389545us-gaap:CommonStockMember2022-03-31 0001389545us-gaap:AdditionalPaidInCapitalMember2022-03-31 0001389545us-gaap:RetainedEarningsMember2022-03-31 00013895452022-03-31 0001389545us-gaap:RetainedEarningsMember2022-04-012022-06-30 0001389545us-gaap:PreferredStockMember2022-04-012022-06-30 0001389545us-gaap:CommonStockMember2022-04-012022-06-30 0001389545us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-30 0001389545us-gaap:PreferredStockMembersrt:DirectorMember2022-04-012022-06-30 0001389545us-gaap:CommonStockMembersrt:DirectorMember2022-04-012022-06-30 0001389545us-gaap:AdditionalPaidInCapitalMembersrt:DirectorMember2022-04-012022-06-30 0001389545us-gaap:RetainedEarningsMembersrt:DirectorMember2022-04-012022-06-30 0001389545srt:DirectorMember2022-04-012022-06-30 0001389545us-gaap:PreferredStockMember2022-06-30 0001389545us-gaap:CommonStockMember2022-06-30 0001389545us-gaap:AdditionalPaidInCapitalMember2022-06-30 0001389545us-gaap:RetainedEarningsMember2022-06-30 0001389545us-gaap:PreferredStockMember2020-12-31 0001389545us-gaap:CommonStockMember2020-12-31 0001389545us-gaap:AdditionalPaidInCapitalMember2020-12-31 0001389545us-gaap:RetainedEarningsMember2020-12-31 00013895452020-12-31 0001389545us-gaap:RetainedEarningsMember2021-01-012021-03-31 00013895452021-01-012021-03-31 0001389545us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-31 0001389545us-gaap:CommonStockMember2021-03-31 0001389545us-gaap:AdditionalPaidInCapitalMember2021-03-31 0001389545us-gaap:RetainedEarningsMember2021-03-31 00013895452021-03-31 0001389545us-gaap:RetainedEarningsMember2021-04-012021-06-30 0001389545us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-30 0001389545us-gaap:CommonStockMember2021-04-012021-06-30 0001389545us-gaap:CommonStockMember2021-06-30 0001389545us-gaap:AdditionalPaidInCapitalMember2021-06-30 0001389545us-gaap:RetainedEarningsMember2021-06-30 00013895452021-06-30 0001389545us-gaap:EmployeeStockOptionMembernby:EmployeesAndDirectorsMember2022-01-012022-06-30 0001389545us-gaap:EmployeeStockOptionMembernby:EmployeesAndDirectorsMember2021-01-012021-06-30 0001389545us-gaap:EmployeeStockOptionMembernby:NonemployeesMember2021-01-012021-06-30 0001389545nby:The2019PreferredWarrantAnd2019CommonWarrantLiabilityMember2022-01-012022-06-30 xbrli:pure 0001389545nby:AvenovaSprayMember2022-04-012022-06-30 0001389545nby:AvenovaSprayMember2021-04-012021-06-30 0001389545nby:AvenovaSprayMember2022-01-012022-06-30 0001389545nby:AvenovaSprayMember2021-01-012021-06-30 0001389545nby:DermadoctorMember2022-04-012022-06-30 0001389545nby:DermadoctorMember2021-04-012021-06-30 0001389545nby:DermadoctorMember2022-01-012022-06-30 0001389545nby:DermadoctorMember2021-01-012021-06-30 0001389545nby:NeutrophaseMember2022-04-012022-06-30 0001389545nby:NeutrophaseMember2021-04-012021-06-30 0001389545nby:NeutrophaseMember2022-01-012022-06-30 0001389545nby:NeutrophaseMember2021-01-012021-06-30 0001389545nby:OtherProductsMember2022-04-012022-06-30 0001389545nby:OtherProductsMember2021-04-012021-06-30 0001389545nby:OtherProductsMember2022-01-012022-06-30 0001389545nby:OtherProductsMember2021-01-012021-06-30 0001389545nby:TotalProductRevenueMember2022-04-012022-06-30 0001389545nby:TotalProductRevenueMember2021-04-012021-06-30 0001389545nby:TotalProductRevenueMember2022-01-012022-06-30 0001389545nby:TotalProductRevenueMember2021-01-012021-06-30 0001389545us-gaap:RevenueFromContractWithCustomerMembernby:DistributorConcentrationRiskMembernby:AvenovaSprayMember2022-04-012022-06-30 0001389545us-gaap:RevenueFromContractWithCustomerMembernby:DistributorConcentrationRiskMembernby:AvenovaSprayMember2021-04-012021-06-30 0001389545us-gaap:RevenueFromContractWithCustomerMembernby:DistributorConcentrationRiskMembernby:AvenovaSprayMember2022-01-012022-06-30 0001389545us-gaap:RevenueFromContractWithCustomerMembernby:DistributorConcentrationRiskMembernby:AvenovaSprayMember2021-01-012021-06-30 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:DistributorAMember2022-01-012022-06-30 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:DistributorAMember2021-01-012021-12-31 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:DistributorBMember2022-01-012022-06-30 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:DistributorBMember2021-01-012021-12-31 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:AmazonMember2022-01-012022-06-30 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:MajorUSRetailerAMember2022-01-012022-06-30 0001389545us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembernby:MajorUSRetailerBMember2021-01-012021-12-31 utr:Y 0001389545us-gaap:EquipmentMembersrt:MinimumMember2022-01-012022-06-30 0001389545us-gaap:EquipmentMembersrt:MaximumMember2022-01-012022-06-30 0001389545nby:ComputerEquipmentAndSoftwareMembersrt:MinimumMember2022-01-012022-06-30 0001389545nby:ComputerEquipmentAndSoftwareMembersrt:MaximumMember2022-01-012022-06-30 0001389545us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2022-01-012022-06-30 0001389545us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2022-01-012022-06-30 00013895452021-01-012021-12-31 utr:D 0001389545nby:SeriesBPreferredMember2022-01-012022-06-30 0001389545nby:SeriesBPreferredMember2021-01-012021-06-30 0001389545us-gaap:EmployeeStockOptionMember2022-01-012022-06-30 0001389545us-gaap:EmployeeStockOptionMember2021-01-012021-06-30 0001389545us-gaap:WarrantMember2022-01-012022-06-30 0001389545us-gaap:WarrantMember2021-01-012021-06-30 0001389545nby:DermadoctorMember2021-11-052021-11-05 0001389545nby:DermadoctorMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:CustomerRelationshipsMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:TradeSecretsMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:TradeNamesMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:CustomerRelationshipsMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:CustomerRelationshipsMember2021-11-052021-11-05 0001389545nby:DermadoctorMemberus-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:TradeSecretsMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:FiniteLivedIntangibleAssetsMemberus-gaap:TradeSecretsMember2021-11-052021-11-05 0001389545nby:DermadoctorMemberus-gaap:IndefinitelivedIntangibleAssetsMemberus-gaap:TradeNamesMember2021-11-05 0001389545nby:DermadoctorMemberus-gaap:GoodwillMember2021-11-05 00013895452021-11-05 0001389545us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-31 0001389545us-gaap:FairValueMeasurementsRecurringMember2022-06-30 0001389545us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-30 0001389545us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-30 0001389545nby:WarrantLiabilityMember2022-01-012022-06-30 0001389545us-gaap:FairValueMeasurementsRecurringMember2021-12-31 0001389545us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-31 0001389545us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-31 0001389545nby:WarrantLiabilityMember2021-01-012021-12-31 0001389545nby:OfficeAndLaboratoryEquipmentMember2022-06-30 0001389545nby:OfficeAndLaboratoryEquipmentMember2021-12-31 0001389545us-gaap:FurnitureAndFixturesMember2022-06-30 0001389545us-gaap:FurnitureAndFixturesMember2021-12-31 0001389545nby:ComputerEquipmentAndSoftwareMember2022-06-30 0001389545nby:ComputerEquipmentAndSoftwareMember2021-12-31 0001389545nby:ProductionEquipmentMember2022-06-30 0001389545nby:ProductionEquipmentMember2021-12-31 0001389545us-gaap:LeaseholdImprovementsMember2022-06-30 0001389545us-gaap:LeaseholdImprovementsMember2021-12-31 0001389545us-gaap:TradeNamesMember2022-06-30 0001389545us-gaap:CustomerRelationshipsMember2022-06-30 0001389545us-gaap:TradeSecretsMember2022-06-30 0001389545us-gaap:TradeNamesMember2021-12-31 0001389545us-gaap:CustomerRelationshipsMember2021-12-31 0001389545us-gaap:TradeSecretsMember2021-12-31 0001389545nby:BankMidwestMemberus-gaap:LineOfCreditMember2021-11-06 0001389545nby:BankMidwestMemberus-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2022-01-062022-01-06 0001389545nby:BankMidwestMemberus-gaap:LineOfCreditMember2022-01-06 0001389545nby:BankMidwestMemberus-gaap:LineOfCreditMember2022-06-30 0001389545nby:EmeryvilleCaliforniaMember2022-06-30 utr:sqft 0001389545nby:RiversideMissouriMember2022-06-30 0001389545nby:The2019DomesticWarrantsMember2019-08-13 0001389545nby:The2019ForeignWarrantsMember2019-08-13 0001389545nby:The2019LadenburgWarrantsMember2019-08-13 0001389545nby:The2019DomesticWarrantsMember2020-12-31 0001389545nby:The2019ForeignWarrantsMember2020-12-31 0001389545nby:The2019DomesticWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2019-12-31 0001389545nby:The2019ForeignWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2019-12-31 0001389545nby:The2019DomesticWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2019-12-31 0001389545nby:The2019ForeignWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2019-12-31 0001389545nby:The2019DomesticWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-31 0001389545nby:The2019ForeignWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-31 0001389545nby:The2019DomesticWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2019-12-31 0001389545nby:The2019ForeignWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2019-12-31 0001389545nby:The2019DomesticWarrantsMemberus-gaap:MeasurementInputSharePriceMember2019-12-31 0001389545nby:The2019ForeignWarrantsMemberus-gaap:MeasurementInputSharePriceMember2019-12-31 0001389545nby:The2019DomesticWarrantsMember2022-06-30 0001389545nby:The2019ForeignWarrantsMember2022-06-30 0001389545nby:The2019LadenburgWarrantsMember2020-12-31 0001389545nby:The2019LadenburgWarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2019-12-31 0001389545nby:The2019LadenburgWarrantsMemberus-gaap:MeasurementInputExpectedTermMember2019-12-31 0001389545nby:The2019LadenburgWarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2019-12-31 0001389545nby:The2019LadenburgWarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2019-12-31 0001389545nby:The2019LadenburgWarrantsMemberus-gaap:MeasurementInputSharePriceMember2019-12-31 0001389545nby:The2021WarrantsMember2022-06-30 0001389545nby:The2021WarrantsMember2021-11-02 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2021-12-31 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputExpectedTermMember2021-12-31 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-31 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2021-12-31 0001389545nby:The2021WarrantsMember2021-12-31 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputPriceVolatilityMember2021-11-02 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputExpectedTermMember2021-11-02 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2021-11-02 0001389545nby:The2021WarrantsMemberus-gaap:MeasurementInputExpectedDividendRateMember2021-11-02 00013895452021-11-02 0001389545nby:ATMProgramMember2021-01-012021-06-30 0001389545us-gaap:SeriesBPreferredStockMembernby:The2021PrivatePlacementProgramMember2021-10-292021-10-29 0001389545nby:ConversionOfSeriesBPreferredStockToCommonStockMembernby:The2021PrivatePlacementProgramMember2021-10-29 0001389545nby:The2021WarrantsMember2021-10-29 00013895452022-01-31 0001389545us-gaap:SeriesBPreferredStockMembernby:The2021PrivatePlacementProgramMember2021-10-29 0001389545nby:ConversionOfSeriesBPreferredStockToCommonStockMember2021-10-012021-12-31 0001389545nby:The2021PrivatePlacementProgramMember2021-01-012021-12-31 0001389545us-gaap:SeriesBPreferredStockMembernby:The2021PrivatePlacementProgramMember2021-01-012021-12-31 0001389545nby:ConversionOfSeriesBPreferredStockToCommonStockMembernby:The2021PrivatePlacementProgramMember2022-01-012022-06-30 0001389545nby:ConversionOfSeriesBPreferredStockToCommonStockMembernby:The2021PrivatePlacementProgramMember2022-03-31 0001389545nby:August2019CommonStockPurchaseAgreementMember2019-07-012019-09-30 0001389545nby:The2019DomesticWarrantsMembernby:August2019CommonStockPurchaseAgreementMember2019-07-012019-09-30 0001389545nby:The2019DomesticWarrantsMembernby:August2019CommonStockPurchaseAgreementMember2019-09-30 0001389545us-gaap:SeriesAPreferredStockMembernby:August2019CommonStockPurchaseAgreement2Member2019-07-012019-09-30 0001389545nby:The2019ForeignWarrantsMembernby:August2019CommonStockPurchaseAgreement2Member2019-07-012019-09-30 0001389545nby:The2019ForeignWarrantsMembernby:August2019CommonStockPurchaseAgreement2Member2019-09-30 0001389545nby:August2019CommonStockPurchaseAgreement2Member2019-07-012019-09-30 0001389545nby:The2019DomesticWarrantsMember2019-09-30 0001389545nby:LadenburgThalmannAndCoIncMember2019-09-30 0001389545nby:LadenburgThalmannAndCoIncMember2019-07-012019-09-30 0001389545nby:The2019LadenburgWarrantsMember2019-07-012019-09-30 0001389545nby:The2019LadenburgWarrantsMember2019-09-30 0001389545nby:The2019DomesticWarrantsMember2019-07-012019-09-30 0001389545nby:The2019ForeignWarrantsMember2020-09-30 00013895452020-07-012020-09-30 0001389545nby:ChinaKingtonMember2020-07-012020-09-30 0001389545nby:NewWarrantsMember2020-09-30 0001389545nby:The2019LadenburgWarrantsMember2020-09-30 0001389545nby:TlfBioInnovation2021WarrantsMember2021-01-15 0001389545nby:IncentiveStockOptionsISOMembernby:The2007OmnibusIncentivePlanMembersrt:MaximumMember2007-10-012007-10-31 0001389545nby:The2017OmnibusIncentivePlanMember2017-03-31 0001389545nby:The2017OmnibusIncentivePlanMember2022-03-062022-03-06 0001389545nby:The2017OmnibusIncentivePlanMember2022-06-30 0001389545nby:The2017OmnibusIncentivePlanMembersrt:MinimumMember2017-03-012017-03-31 0001389545nby:IncentiveStockOptionsISOMembernby:The2017OmnibusIncentivePlanMember2017-03-012017-03-31

SEC Form 10-Q filed by NovaBay Pharmaceuticals Inc.